Design challenges for electronic medication administration record systems in residential aged care facilities: A formative evaluation by Tariq, Amina et al.
This is the author’s version of a work that was submitted/accepted for pub-
lication in the following source:
Tariq, A., Lehnbom, E., Oliver, K., Georgiou, A., Rowe, C., Osmond, T., &
Westbrook, J.
(2014)
Design challenges for electronic medication administration record systems
in residential aged care facilities: A formative evaluation.
Applied Clinical Informatics, 5(4), pp. 971-987.
This file was downloaded from: https://eprints.qut.edu.au/92969/
c© Schattauer Publishers
This article is not an exact copy of the
original published article in Applied Clinical Informatics. The
definitive publisher-authenticated version of is available online at:
http://doi.org/10.4338/ACI-2014-08-RA-0062
Notice: Changes introduced as a result of publishing processes such as
copy-editing and formatting may not be reflected in this document. For a
definitive version of this work, please refer to the published source:
https://doi.org/10.4338/ACI-2014-08-RA-0062
Design challenges for electronic medication administration record systems 
in residential aged care facilities: A formative evaluation 
 
A.Tariq,  E. Lehnbom, K. Oliver, A., Georgiou, C. Rowe, T. Osmond, & J. Westbrook. 
 
Abstract: 
Introduction 
Electronic medication administration record (eMAR) systems are promoted as a potential 
intervention to enhance medication safety in residential aged care facilities (RACFs). The purpose of 
this study was to conduct an in-practice evaluation of an eMAR being piloted in one Australian 
RACF before its roll out, and to provide recommendations for system improvements. 
Methods 
A multidisciplinary team conducted direct observations of workflow (n=34 hours) in the RACF site 
and the community pharmacy. Semi-structured interviews (n=5) with RACF staff and the 
community pharmacist were conducted to investigate their views of the eMAR system. Data were 
analysed using a grounded theory approach to identify challenges associated with the design of the 
eMAR system. 
Results 
The current eMAR system does not offer an end-to-end solution for medication management. 
Many steps, including prescribing by doctors and communication with the community pharmacist, 
are still performed manually using paper charts and fax machines. Five major challenges associated 
with the design of eMAR system were identified: limited interactivity; inadequate flexibility; 
problems related to information layout and semantics; the lack of relevant decision support; and 
system maintenance issues.We suggest recommendations to improve the design of the eMAR 
system and to optimize existing workflows. 
Discussion 
Immediate value can be achieved by improving the system interactivity, reducing inconsistencies in 
data entry design and offering dedicated organisational support to minimise connectivity issues. 
Longer-term benefits can be achieved by adding decision support features and establishing system 
interoperability requirements with stakeholder groups (e.g. community pharmacies) prior to system 
roll out. In-practice evaluations of technologies like eMAR system have great value in identifying 
design weaknesses which inhibit optimal system use. 
 
1. Introduction 
Medication management is one of the fundamental collaborative processes in residential aged care 
facilities (RACFs) which require RACF staff, general practitioners (GPs) and community pharmacists 
to coordinate their activities [1–3]. For medication management, this includes prescribing, ordering, 
delivering, administering and monitoring. Medication safety is a major challenge for the 
elderly population in RACFs [2–4]. Gurwitz et al. [2] in a study based on two long-term care facilities 
in Canada found an adverse drug event rate of 9.8 per 100 resident-months. Almost a third 
(28%) of the 885 adverse drug events identified in the study were deemed fatal, life threatening, or 
serious [2]. 
 
Medication administration has been identified as the most vulnerable to error in RACFs [4–7]. 
Medication administration involves the delivery of the right medication and dosage to the right resident 
at the right time using the right route [8].Pierson et al. in a US-based study reported that 47% 
of the 2,731 reported medication errors in 25 nursing homes occurred during administration [9]. 
The 2007 report by the US Institute of Medicine (IOM), estimated medication administration errors 
in long term residential care occur at a rate of 6–20 per 100 doses, with drug omissions as the most 
frequent [6]. A recent study of medication administration errors in 13 care homes in the UK, using a 
barcode medication administration (BCMA) system reported that 45% of errors (n=2,289) involved 
attempts to give medication at the wrong time [4]. 
 
As is the case in other health care settings, the use of information and communication technology 
(ICT) in aged care settings has the potential to add value by improving the quality and safety of care 
[10–14]. However, when compared to acute care settings there is very limited evidence about the use 
and impact of technological interventions to improve medication safety in RACFs [15,16]. A few 
studies have explored the use of electronic medication administration records (eMAR) in RACFs. 
Scott-Cawiezell et al. [17] described use of an eMAR system in five nursing homes in the United 
States, and reported streamlining of the medication administration process by provision of real-time 
information, improved legibility and alerts prompting staff of potential medication safety issues. 
 
However, the authors identified streamlining of the underlying processes and appropriate adaption 
of the system to their implementation context as a prerequisite for the realisation of intended benefits 
[17]. Similar results are suggested by Vogelsmeier et al. in their study which explored the underlying 
nature of workaround in relation implementation of an electronic medication administration 
record in five USA nursing homes and identified the potential risks of workarounds on medication 
safety [18]. The study identified limitations in technological design and failure to reengineer related 
processes to interface with the eMAR system as the primary causes for adoption of workarounds 
which may impose risks to residents’ medication safety [18]. 
 
The success of ICT interventions such as eMAR systems, depend to a large degree on their alignment 
with the context of implementation [19, 20].In-practice formative evaluations are a valuable 
process by which to identify potential system design improvements within their context of 
use[19,20].The Australian experience of implementing eMAR systems in RACFs remains largely 
underreported in the literature[21]. The implementation of an eMAR system in an RACF by one of 
the largest aged care provider organisation in Australia, with a planned roll-out of the system across 
remaining sites (n=77) in New South Wales (NSW) and Australian Capital Territory (ACT)presented 
an opportunity to conduct an in-practice formative evaluation. A formative evaluation was 
chosen in order to provide feedback to the system vendors to facilitate the optimal implementation 
of the system at the remaining sites. The aim was to identify limitations of the system and to suggest 
system improvements prior to the roll out. 
 
2. Materials and Methods 
 
2.1 Research Setting 
 
The study RACF site (78 residents) had been piloting the eMAR system for almost 24 months at the 
time of study. The community pharmacy, the primary medication supplier for the study RACF site, 
also participated in the study. 
 
The Clinical and Care Management system, developed by iCareHealth [22], had been implemented 
across all organisational RACF sites in 2006. The system’s primary function is to facilitate 
electronic documentation and record keeping of residents’ clinical documentation such as: care 
plans, progress notes, assessments (e.g. pain) and the aged care funding instrument (ACFI). The 
eMAR system was developed by iCareHealth as a module of the existing Clinical and Care Management 
system. The eMAR system went through a few software and hardware changes (redefinition of 
user groups and associated access rights, change of tablets) after initial implementation at the pilot 
site. The organisation had a plan to roll out the eMAR across all the remaining 77 sites by July 2014. 
However, no formal evaluation of the system had been conducted post its implementation at the 
pilot site. A formative evaluation was therefore identified as necessary to rectify system limitations 
prior to the roll out. 
 
2.1.1 Medication charting in the RACF 
 
 Figure 1 presents an overview of how data are entered into the eMAR system. Prescribing continues 
to be on paper medication charts. The community pharmacy supplies printed copies of medication 
charts to the RACF. Any changes to residents’ medication regime (e.g. adding, ceasing, or 
modifying medications) are performed by doctors on the paper medication charts. These charts are 
then faxed by RACF staff with an order cover sheet to the community pharmacy. RACFs can send 
electronic order messages to the pharmacy using the messaging interface of the eMAR system. However, 
this does not eliminate the need to fax the complete paper medication chart. It is the responsibility 
of community pharmacy staff to enter the data from the paper medication chart into the 
eMAR system and to dispense medications. The community pharmacy has a number of disparate 
electronic systems which serve different purposes in support of their work processes. These include 
a dispensing system, a medication packing system and a data entry component of the RACF’s eMAR 
system. An integrated data entry interface allows the pharmacist to simultaneously enter data in all 
systems. The interface at the pharmacy is password protected. The registered nurse (RN) at the 
RACF who is also the site manager cross-checks the updated electronic medication profiles provided 
by the pharmacist with the paper medication charts. In case of discrepancies, the manager 
communicates the corrections to be made to the community pharmacist over the telephone. If no 
discrepancies are found, the RN ‘approves’ the updated medication profile, which then becomes visible 
on the eMAR system. RACF staff can access these profiles on tablet computers to administer 
and document during administration rounds. The tablets and computers at the RACF are password 
protected. The RACF manager and staff need to login for data synchronisation and sending messages 
to the pharmacy. 
 
2.1.2 Use of the eMAR for medication administration 
 
The eMAR system communicates over the internet to send and receive data but also offers offline 
the capability to continue with medication administration in situations where there is no internet 
connection. Once the internet becomes available data needs to be re-synchronised to send and receive 
the latest changes to residents’ medication profiles. As the RACF does not have a wireless internet, 
staff must synchronise the eMAR system pre and post administration rounds, to access and 
upload the latest medication profiles. Medication administration rounds at the site were carried out 
using two tablet computers. The facility is spread across two levels. The tablets are configured to be 
logged in for clients residing on a specific level. Table 1 summarises the key steps involved in typical 
medication administration round at the RACF site. 
 
2.2 Data Collection 
 
A qualitative study design was chosen because of its ability to allow a context-rich exploration of the 
eMAR system. Researchers met with the site manager, RACF staff and the community pharmacist to 
explain the purpose of the study and invite them to participate in the study. The participants were 
recruited using purposive sampling methods – based on their involvement in the medication process 
in the RACFs. The site manager was approached to participate in an initial discussion, given her 
role in overseeing and reviewing the entire medication management process. Participation was voluntary 
and participants did not receive any remuneration for their participation. 
 
Data were collected over a six month period (May to October 2013). The three main sources of 
the data used in this study were: 
 
1. Non-participant field observations; scripted and unscripted follow-up probes were used to elicit 
further information during observations. The data were collected by three members (two qualified 
pharmacists and a human factors researcher) of the research team. All members had training 
and experience in qualitative data collection. We conducted direct observations of the workflow 
(n=34 hours (3.4 hours per session), over 10 days) at the RACF site and community pharmacy. 
Two pilot observation sessions were conducted by all three members; their notes were compared 
and discussed to establish consistency in the data collection process. The observations focused on 
understanding how the participants (included RACF staff (n=4), RACF manager, and the community 
pharmacist) use the eMAR system in their daily work and information flows. All the observed 
RACF staff had appropriate qualification and training (certificate III or above in nursing). 
Field notes and photographs were the primary form of data collected during observations. 
 
2. Thirty minute semi-structured interviews with the end users of the system (included RACF staff 
(n=3), RACF manager and the community pharmacist). An interview guide (Appendix I) was 
developed based on existing literature [9,16,28] and preliminary observations to understand current 
work practices associated with use of the eMAR system and staff perceptions of challenges 
associated with the design and operation of the eMAR system. All interviews were recorded and 
transcribed verbatim by a professional transcribing service and validated by a member of the research 
team. 
 
3. An analysis of artefacts used in the medication ordering and administration process at the 
RACFs and the community pharmacy. This also included a review of education materials (user 
manuals etc.) provided by the system vendor to train the RACF staff. 
 
4. Ethics approval for the study was obtained from Human Research Ethics Committee (HC13091) 
at University of New South Wales, Sydney, Australia. 
 
 
2.3 Analysis 
 
We used thematic analysis to derive categories relating to the design challenges associated with the 
eMAR system [23]. The process was iterative and generated from the ground up using actual data. 
The grounded analysis approach was employed to analyse the data within a multi-phase process 
[23]. One of the authors (AT) performed the initial open coding of the data which was reviewed by 
the research team to identify the need for any restructuring of the coding scheme. Five iterations 
were made to accomplish the final coding scheme. Electronic management and coding of data using 
QSR NVivo (v.9) software supported data management and automatic collation of all data extracts 
within each code. Revision and finalisation of categories was achieved via triangulation and consensus 
between all researchers [24]. Participants were also provided with a written summary of findings 
in the form a newsletter and given an opportunity to provide feedback. The findings presented in 
the next section were shared in detailed presentations to participants and key organisational stakeholders, 
which included members of the Information Technology Service Centre (ITSC) department, 
in November 2013. The organisational ITSC team was assigned the responsibility to communicate 
the required changes to the eMAR system to the vendor before its organisation-wide roll 
out. 
 
3. Results 
 
The in-depth analysis of the data identified five categories of challenges associated with the design 
and use of the eMAR system. 
 
3.1 Limited Interactivity 
 
The eMAR messaging interface in the community pharmacy has an alert icon which turns red if 
there are new or unread messages from a RACF, but remains green if all messages have been read by  
 
 been received, the icon is ‘read only’ and does not navigate the pharmacist to the actual message. 
The pharmacist has to manually search through all of the RACFs to which they provide a service in 
order to identify which RACF has sent the message. As explained by the community pharmacist: “It’s 
just an alert. So when there’s a red dot, if you’ve got 20 facilities there you’ve got to go through and click 
to see where that red dot’s coming from... it’s very frustrating and it could just be for a nail polish for 
[resident X]”. The icon also does not establish the urgency of the order, which may result in the pharmacist 
spending time searching for the order, only to find that a non-urgent order (e.g. request for 
cosmetics for a resident) has been placed. Similar issues are experienced at the RACF end, the asterisk 
icon indicating that a resident’s medication profile has changed in the last 24 hours does not offer 
any navigational support to the RACF staff to identify the details of the changes (i.e which medication 
has been ceased, added or changed). 
 
3.2 Inadequate Flexibility 
 
At present, the RACF staff including managers can access residents’ medication profiles as read only. 
All changes to these profiles have to be completed by a community pharmacist. As explained by the 
RACF manager: “When we admit them, they’re [residents] in the [EHR system] but they’re not in the 
[eMAR] system. Cause we can’t adjust anything on that [eMAR] system. It’s all directly pharmacy. We 
can’t take medications off, or add them on” (RACF Site Manager). Medications can only be scheduled 
to be administered at one of eight pre-defined times ( Figure 3). The community pharmacist described 
this as problematic for residents where doctors have given clear instructions to administer 
medications at a specific time: “I’ve got one lady, she has to get her Tamoxifen for breast cancer, but 3 
o’clock is not an allocated dose time. It’s 8 o’clock, 12 o’clock, 5 o’clock and 8 o’clock” (Community 
Pharmacist). 
 
To overcome this design limitation, the pharmacist would enter the specific administration 
time in the ‘Full direction’ data entry field ( Figure 3). Consequently the medication appeared for 
the resident in their dinner time (5pm) list, but staff were required to read the directions on the 
eMAR carefully to note that the medication actually needed to be administered at 8:30 pm. 
The system did not allow entry of the correct administration instructions for specific medications 
like patches. A patch needs to be applied to the resident at the prescribed time (for example, 8am) 
and then removed from the resident after a certain time (for example after 12 hours at 8pm). The 
eMAR system has the capacity to only enter one administration time. The pharmacist therefore has 
to enter one order for a patch twice in the system. The first order is to apply the patch at ON time. 
The second order is to remove the patch at OFF time ( Figure 4). If the pharmacist does not enter 
two orders for one patch, it will appear only once in the resident’s profile which may result in either a 
missed application or removal of the patch. 
 
3.3 Issues in Information Layout and Semantics 
 
Several issues with information layout and semantics were identified. Pharmacists need to assign the 
medication to a category from a predefined drop down list. The options in this list (Antibiotics, 
Packed, Non-Packed, Short-term, Schedule 8, Schedule 4D) are not mutually exclusive (Figure 5). 
For example, an antibiotic agent in tablet or capsule formulation can be categorised as an ‘Antibiotics’. 
However, the antibiotic in most cases is a short term treatment and packed in a separate 
Webster pack from regular medications to indicate to staff that this is a short term treatment. The 
present system does not allow the pharmacist to assign two categories, for instance both ‘Antibiotics’ 
and ‘Short Term’ to a medication. The assignment of category to medications like antibiotics becomes 
further complicated if these are prescribed to be administered in liquid form, which therefore 
cannot be packed in the Webster pack. In such cases antibiotics may be categorised as ‘Antibiotic’, 
‘Short-Term’ and ‘Non-Packed’. As the present system allows assignment of one category to the 
medication, it is at the discretion of the community pharmacist to decide in which category the antibiotic 
should be listed. The variability in assignment of categories and associated possible packing 
type requires staff to see if they have administered medication from all Webster packs for the resident 
and also carefully cross check the number of non-packed medications to be administered to the 
resident. 
 
Non- regular medications (eg weekly, fortnightly or monthly) do not have a specific category. To 
ensure that medications are administered correctly, the pharmacist is required to appropriately uncheck 
the auto checked boxes to select the days when medication should be administered. A further 
issue was inconsistencies in information layout across different views of the system. An example of 
this is the use of dissimilar field titles across different views of the same information ( Figure 6). 
The pharmacy data entry interface had two fields to specify directions (Direction (short); Full Direction 
(long)). The full direction appear as “Instruction” in the medication profiles of residents viewable 
at the RACFs and the same content appeared under the “Frequency” column in the administration 
profile viewable on the tablets. 
 
Given the variation in medication formulation types available for administration, dosage units 
will naturally vary. The administration view in the eMAR system currently represents all formulation 
doses using numbers. For medications in capsule or tablet form this may be adequate, however 
for non-packed medications such as liquids, puffers or creams the number listed in ‘Dose’ 
requires further interpretation by staff administering medications. To compensate for this limitation, 
the frequency column in the administration view (which is labelled “direction” at the pharmacy 
system end) presents the details of the units ( Figure 6). 
 
3.4 Minimal Decision Support 
 
The eMAR system offered very limited decision support for the RACF staff. Decision support in this 
context relates to alerts and information that can facilitate staff in their administration decisions (for 
example decision to administer a PRN (as required medication)).The system has no capacity to offer 
staff alerts based on vital signs or pain scores documented in the assessment forms and progress 
notes. The computer tablets are configured only to display residents’ medication profiles and do not 
offer real-time access to pertinent documentation, for example progress notes. Such clinical information 
is used by staff to inform their administration decisions as noted during observations: “The 
sequence of medication administration is decided by the staff. However it is informed by information 
like residents’ doctor appointments, PRN requests by residents, residents’ personal preferences etc. There 
is no automation of these features. It is entirely up to the staff to remember and perform administration 
by manually taking these factors into account”(Observation Notes). Stocked medications also need to 
be managed manually by RACF staff. This may not be a problem for packed medications which are 
delivered in weekly Webster packs but was observed to be problematic for non-packed medications 
as staff were observed running out of non-packed medications(e.g. syrups; eye drops) during administration 
rounds. 
 
3.5 System Maintenance Issues 
 
Delays in data synchronisation, which means updating of the eMAR system records at the RACF 
with the latest changes made at the community pharmacy, were also identified as an issue. If the 
synchronisation 
took too long, RACF staff would assume that the pharmacist had not updated the records 
and would try to contact the pharmacist to have this rectified when in fact there was nothing to 
rectify. The pharmacist also identified delays in managing orders due to internet crashing: “I [community 
pharmacy] crashed on the internet once and we didn’t realise until they [RACF] rang and said, 
“Oh the order for Ventolin for [resident X] didn’t come.” So then I rang [eMAR vendor] and they rebooted 
the [eMAR system]” (Community Pharmacist). 
 
At the RACF end, the RACF site manager highlighted challenges of coping with system crashing: 
“Last Friday night, all toughbooks crashed, which was ok ‘cause we just printed off all the medication 
charts, so there is a back-up plan. But trying to find somebody to come and fix that was a bit of an 
issue”. When the system is down, it is necessary to either print the signing sheets at the RACF or ask 
the pharmacist to print and courier medication charts (in case the eMAR system is down at RACF) 
which can be cumbersome and time consuming. As explained by one of the RACF staff members: 
“The manager said well, I guess we’re going to have to do it manually, and it’s this thick! (gestures with 
the hands). Because it’s for every resident, like [for] each single tablet, a [separate] sheet. And you have 
to sign… Oh, mygod! It’s so time consuming!” (RACF Staff Member). 
 
4. Discussion 
 
The medication management process in RACFs requires coordination across geographically distributed 
professional groups and involves activities that are interdependent and inseparable [25–27]. 
Our study results show that the work practices of both RACF staff and community pharmacists are 
greatly affected by the implementation of the eMAR system. As the scope of the implemented eMAR 
system was confined to the medication administration stage, it offered limited capacity to address 
the information exchange issues (e.g. transcription errors) related to the prescribing and ordering 
stages of the RACF medication management [28]. Introduction of end to end shared electronic system, 
with appropriate interoperability, can minimise the risks associated with information double 
handling and use of hybrid systems. The major design considerations for such systems would need 
to effectively enable transmission of information between different systems across various settings 
(GP practices, community pharmacies and RACFs). For aged care settings, these systems need to 
carefully integrate administrative (e.g. medication stock) and clinical (e.g. residents’ allergies) information 
[25–27]. The electronic transfer of medication charts between community pharmacies and 
RACFs would substantially streamline the current manual process and reduce the costs associated 
with the use of fax as the primary exchange mechanism [28]. 
 
Our study identified various system design challenges which limit the realisation of the full potential 
of the eMAR system and may result in unintended technology hazards in both RACFs and 
community pharmacies, most of which were not anticipated at the time of system implementation[ 
29,30]. Recent studies investigating the impact of electronic prescribing on community pharmacy 
workflows have identified various design weaknesses which include inadequate interoperability, 
synchronisation delays, user interface issues and inconsistent formats which negatively impact 
community pharmacy workflows [31, 32]. Our results concur with several of the design weaknesses 
identified in these studies and their impact on community pharmacy workflows. The existing eMAR 
system relies on pharmacists’ resilience to prevent and recover from data entry errors. The community 
pharmacist sometimes had to take additional steps beyond the system to cope with the lack of 
support provided by the system[33]. Primary examples of these included double data entry for 
patches, assigning specific administration times for medications, synchronisation issues and coping 
with inconsistent layouts across disparate systems. Such data entry requirements require additional 
alertness and a high amount of memorisation (for cross system data entry) therefore increasing 
pharmacists’ cognitive burden and risk of data entry errors [32, 33]. 
 
One of the major design challenges identified related to lack of consistency in information 
layouts and limited considerations of information semantics in the system design. Striving for information 
consistency in health care settings is not only a problem of technical integration, but also of 
aligning inter-organisational work processes [34–36]. Achieving the right degree of information 
consistency therefore requires input from all stakeholders about residents’ medication information 
to negotiate how to stabilise the content and meaning of coordinative artefacts like medication 
charts [35,37,38]. These decisions on the extent of information standardisation are of fundamental 
value to the design of technological interventions like eMARs as their primary objective is the exchange 
of useful information in any format (paper or electronic) across multiple settings. 
 
Results from the study provide immediate as well as long term value to the RACF organisation in 
optimising the design and use of the eMAR system. Immediate value can be achieved by addressing 
some of the design challenges, like improving interactivity of the alerts by navigating the user to the 
required information. Further, reducing inconsistencies in data entry by offering clear guidelines to 
users for example regarding the categorisation of each drug by medication type (antibiotics, eye 
drops, creams etc), packing type (packed or non-packed) and its intended administration duration 
(regular, short-term, pro re nata (PRN), weekly) etc. The results point to the need for a dedicated IT 
support team and continuous commitment by the organisation in relation to appropriate resourcing 
for IT infrastructure to minimise connectivity issues [39]. This also includes consideration of enabling 
wireless internet in the RACFs to improve the synchronisation pre and post medication 
rounds. However the organisation needs to carefully address the security and privacy risks associated 
with wireless internet prior to its enablement. 
Long term value can be achieved by sharing the results of the evaluation with the vendor in order 
to address issues identified (e.g. appropriate decision support) in future releases. Findings also in- 
crease organisational awareness of how to avoid these challenges in future stages of system implementation 
and setting priorities prior to the organisation-wide roll out[19,40].The implementation 
and use of electronic systems like eMARs, in RACFs are contingent on factors which span multiple 
stakeholders and organisations and which may not always be evident through the prism of a single 
stage of medication management [41, 42]. A single RACF organisation with multiple sites receives 
services from a large number of community pharmacies and GP practices. There are likely to be 
subtle differences in the technology infrastructures and work processes of individual settings. For 
instance, in this study, the community pharmacy had three disparate systems, each with its own 
underlying schema and architecture. Outlining existing systems of the individual settings, identifying 
associated operational nuances and establishing interoperability requirements is vital for informing 
the design and maintenance of eMARs for supporting collaborative health care processes 
[43]. This will facilitate in the establishing well defined goals of these interventions and understand 
how they evolve during and post-implementation [44, 45]. 
 
Finally, it is important to emphasise the potential risks to residents’ safety attributed to the flawed 
eMAR design. For example, the mismatch between the assigned administration time on the system 
and what appears in the instructions increases the risk of administering medications at wrong time. 
The synchronisation and system interactivity limitations can lead to delays in receiving orders at the 
pharmacy, which increases the risk of missed dose errors. The dual entry of patches and variability 
in categorising medications not only compromises information integrity in RACF systems, but also 
corrupts pharmacy records (as they are entered through the same data entry interface). This process 
of duplicate data entries is crucial for RACF residents as the accuracy of their medical records across 
different settings could be compromised. Studies in both hospitals and aged care settings have identified 
overcoming design limitations of technological interventions that span multiple healthcare settings 
as a pre-requisite to achieving their benefits and minimising risks to patient safety [46–49]. Although 
the primary aim for implementing systems like eMAR in health care settings is to improve 
medication safety, our study identifies that weaknesses in system design and integration can inhibit 
its realisation in practice. 
 
This study had some limitations. First the data were collected from a single RACF site and community 
pharmacy. While these results may be transferable to Australian RACFs in general, variance 
in technological infrastructures of these settings may result in additional considerations. However, it 
is important to note that the electronic systems used by the participant pharmacy are commonly 
used by Australian community pharmacies. Although the findings from this study may not be able 
to be generalised to RACF settings at the international level, the evaluation of electronic systems in 
collaborative health care settings is of global relevance: therefore, readers of this study may be able to 
infer some relevance for their local health care settings. 
 
Clinical Relevance Statement 
 
This study will help aid in the design and implementation of electronic medication management 
systems in RACF settings. The findings outline the significance of identifying design weaknesses 
which negatively impact workflows of involved stakeholder organisations (e.g. RACFs, community 
pharmacists) in collaborative healthcare management. Study emphasizes the instrumental role of 
in-practice formative evaluation to determine the effectiveness and efficiency of eMAR design before 
the organisation wide roll out. 
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